Results 61 to 70 of about 1,878,367 (184)

A rare presentation of myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) as acute hemorrhagic longitudinally extensive transverse myelitis

open access: yesThe Egyptian Journal of Radiology and Nuclear Medicine, 2023
Background Myelin oligodendrocyte glycoprotein antibody-associated disease is usually associated with optic neuritis, acute disseminated encephalomyelitis or transverse myelitis.
Aniket Nerlekar   +5 more
doaj   +1 more source

COVID-19 associated myelitis: A case series

open access: yesMedical Journal of Dr. D.Y. Patil Vidyapeeth, 2022
Spinal cord involvement in COVID-19 infections can be varied and may present as acute transverse myelitis, acute necrotizing myelitis, neuromyelitis optica spectrum disorder, Myelin oligodendrocyte-associated glycoprotein (MOG) antibody myelitis, and ...
Pravin Naphade   +4 more
doaj   +1 more source

Quantitative MRI Uncovers Subtle Cortical Damage in Myelin Oligodendrocyte Glycoprotein Antibody‐Associated Disease

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine whether myelin‐sensitive quantitative MRI reveals microstructural abnormalities in normal‐appearing cortex (NACtx) in myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), indicating that conventional MRI underestimates remission residual cortical injury.
Valentina Camera   +20 more
wiley   +1 more source

Diphtheria, pertussis, and tetanus vaccine-induced extensive longitudinally extensive transverse myelitis: A case report [PDF]

open access: yes, 1970
Transverse myelitis (TM) has been reported in association with vaccination, including post-diphtheria, pertussis, and tetanus (DPTw) vaccination. Here, we report the case of a 21-month-old female child presented with loss of neck control with a history ...
Tiwari, Ved Pratap   +3 more
core   +1 more source

“Low‐Positive” MOG‐IgG Cases Among Adults With a First Event Suggestive of Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To determine the prevalence and clinical characteristics of patients with “low‐positive” (LP) MOG‐IgG (titres 1:160–1:320) among adults with a first demyelinating event (FDE) suggestive of multiple sclerosis (MS). Methods From the Barcelona CIS inception cohort, we included adult patients with serum collected ≤ 6 months from the FDE.
Javier Villacieros‐Álvarez   +29 more
wiley   +1 more source

Clinical characteristics and predictive factors of recurrent idiopathic transverse myelitis

open access: yesFrontiers in Neurology
BackgroundIdiopathic transverse myelitis (iTM) is defined as an inflammatory myelopathy of undetermined etiology, even after a comprehensive workup to identify other possible causes. Generally, the characteristics of recurrent iTM are not clearly defined.
Eun Kyoung Lee   +2 more
doaj   +1 more source

Fulminant Acute Ascending Hemorrhagic Myelitis Treated with Eculizumab

open access: yesFrontiers in Neurology, 2017
We describe an 18-year-old patient who developed back pain, rapidly ascending sensomotory deficits, bladder dysfunction, Lhermitte’s sign, absent abdominal reflexes of all three levels, brisk tendon reflexes, and positive Babinski’s sign.
Nang Boe Ohnmar Hsam   +6 more
doaj   +1 more source

Neurosarcoidosis presenting as longitudinally extensive myelitis: Diagnostic assessment, differential diagnosis, and therapeutic approach

open access: yesTranslational Neuroscience, 2022
Neurosarcoidosis is an uncommon and multiform clinical entity. Its presentation as an isolated longitudinal extensive transverse myelitis (LETM) is rare and challenging to identify.
Cicia Alessandra   +6 more
doaj   +1 more source

Cervical longitudinally extensive myelitis after vaccination with inactivated virus-based COVID-19 vaccine

open access: yesRadiology Case Reports, 2022
Myelitis, including longitudinally extensive transverse myelitis (LTEM), is reported in more than forty patients after coronavirus disease 2019 (COVID-19).
Mahsa Sepahvand, MD   +3 more
doaj   +1 more source

The Comprehensive Live Cell‐Based Cytotoxicity Assay for Monitoring Disease Activity and Guiding Rescue Therapy in Acute Attacks of NMOSD

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Neuromyelitis optica spectrum disorder (NMOSD) is a devastating neurological disease that lacks serological biomarkers that can accurately reflect disease activity. We established a live cell‐based assay (LCBA) using serum with endogenous complement to quantify the overall cytotoxicity, offering a novel functional tool for monitoring
Xiaona Xu   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy